Member Info for unvrkw

On its way, replacing the primark store! So the owned hotels all have a roce of more than 15%, not bad going and medium term, 2017 returns will increase. The pipeline for the next two years is good

Should be ok, update on new hotels and Brexit impacting rev par for the better. Hoping this supports the sp and we might start to push £1??

good position I hope dibs. invested a few quid here now so me and Richard are on the same page! all in isa and sip so hopefully over the next 20 years this can fly nice and high and do me a good favour. good day, might creep towards the 28 pence?

Usual!! Good show

At $5 dollars and I think that's reserved number as the last quote was 200 million kits needed. Let's say, revenue 2018 up to £60 million dreaming, what sp does that give us Dibs

God we need this moving. By the time this gets listed china will probably own most of Britain anyway

Also see the potential buyer has half year results out this week

Agree. I read this division in itself didn't actually make money on its own. It lost about £95k in the results. So that plus the CE marking now happening encourages the sale. We also as you say have CD4 coming which they have been willing to say will add to short term revenues, 2nd half 2017. The cash could bank roll expansion in assets if needed to make more? Support India which is now coming on line and they describe growth in USA, Middle East, India at least. When they have also started to indicate the market potential, how big it is, down in writing etc, Brexit I think odx are now starting to flex the muscles to create value?

Again until the update when ever this may be and of course if good it should hit £1.50 ish straight away. So for me now the investment waits for the update. Gla

That's it, can't afford anymore

The World Health Organisation has estimated that around 22 to 23 million CD4 kits could be required per year, retailing at $5. “There is a significant market out there and everyone we speak to in this global health arena is saying we need this product, we need it desperately, right down at field level,” said Mr Shepherd.

Note the points below. They expect CD4 along with Prune is to add to revenues now in the short term! They have 10,000 components ready to be assembled to start the next phase which is ready to commence as all other trials to this point have been successful. "We have made good progress on our key Visitect® CD4 development project and we have also covered much ground in bringing our Pune facility to a state of operational readiness and these activities are expected to contribute to growth in shareholder value over the shorter term.

up slightly but I am not sure everything is priced in . brexit is certainly helpful and will probably reduce a level of extra fund raising through equity as the cash is there to spend. I like the fact new growth from inida will come on line from year end. the sell off I am sure has been considered for sometime but approvals where needed to generate real value and everything sits on growth in our higher margin areas and new products. cd4 seems to be written about in a manner where the technical, can really go wrong development is done but we shall see. holding tight, next updates are really product updates until financial numbers.

i think they are connected. I think odx will have further value as the hard work has been done and these are all certified and ready for sale. so not just based against sales but now going forward potential there should be some sort of premium plugged in. there aren't going to give away just on the past now the new ones are online. hence also the interest from someone else as they are now available.

Invest in from an ethical point. They seem to be very focus, very clear on their aims and what they need to achieve. The links, conferences around the world and it feels as though they have jumped somewhat from developing to now showing off, talking about their products more and selling. Underneath this is our positive Brexit help which never does any company of this size any harm,

A positive week for the company in Atlanta. There are several front, malaria seems to be involved more along with hiv and the link to smartphone technology which is being used in many health fields seems essential. We could get an update on whether any deals in USA have been signed ?? It does seem strange however long term. If they create something of high value the cost to buy the business by one of the huge global players seem nothing even if the sp raised to £1 a share

It's quite red across the board in different places. I took the gain at 90.8 and placed it into another share that has results next week and longer term already invested. I have my original, valued investment here and will wait for sometime.

Well I got a few more today just in case. You never know they might give us a little more. Some very positive feed on Twitter about the conferences there at and people being met. Small amounts of insight into what there doing, drumming up more business all the time!

Are you a big holder? I'm in now around 25k, so enough to make a difference to me if it does well.

we know solid cash numbers. really hope for a little more insight, update on the future that gives the sp a lift and some hope. as a business in AIM the worry can be dilution and bust but hopefully we are over a lot of this and can move forward. dibs, I just sold some legal and general this morning at a 10% gain and bought another 5k here?? we shall see.